Search
Close this search box.

Day: July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

READ MORE ...

Chief Justice declares July 15 to 19 as ADR Week

Justice Mrs Gertrude Sackey Torkornoo, the Chief Justice, has declared 15 to 19 July 2024 as Alternative Dispute Resolution (ADR) week nationwide.

It would be the second of the three series observed thrice yearly, apart from March and November.

In a…

READ MORE ...